ASTH vs. BILI, WSC, QXO, ETSY, MARA, LYFT, TNET, FTDR, CARG, and CLVT
Should you be buying Astrana Health stock or one of its competitors? The main competitors of Astrana Health include Bilibili (BILI), WillScot Mobile Mini (WSC), QXO (QXO), Etsy (ETSY), MARA (MARA), Lyft (LYFT), TriNet Group (TNET), Frontdoor (FTDR), CarGurus (CARG), and Clarivate (CLVT). These companies are all part of the "business services" industry.
Astrana Health vs.
Bilibili (NASDAQ:BILI) and Astrana Health (NASDAQ:ASTH) are both computer and technology companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, community ranking, profitability, dividends, analyst recommendations, media sentiment, institutional ownership, earnings and risk.
16.1% of Bilibili shares are held by institutional investors. Comparatively, 52.8% of Astrana Health shares are held by institutional investors. 22.2% of Bilibili shares are held by company insiders. Comparatively, 8.5% of Astrana Health shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.
Bilibili currently has a consensus target price of $19.69, indicating a potential upside of 12.71%. Astrana Health has a consensus target price of $63.67, indicating a potential upside of 81.03%. Given Astrana Health's higher probable upside, analysts clearly believe Astrana Health is more favorable than Bilibili.
In the previous week, Bilibili had 2 more articles in the media than Astrana Health. MarketBeat recorded 7 mentions for Bilibili and 5 mentions for Astrana Health. Bilibili's average media sentiment score of 0.71 beat Astrana Health's score of -0.01 indicating that Bilibili is being referred to more favorably in the media.
Astrana Health has a net margin of 3.63% compared to Bilibili's net margin of -10.73%. Astrana Health's return on equity of 9.37% beat Bilibili's return on equity.
Astrana Health has lower revenue, but higher earnings than Bilibili. Bilibili is trading at a lower price-to-earnings ratio than Astrana Health, indicating that it is currently the more affordable of the two stocks.
Bilibili has a beta of 0.81, meaning that its stock price is 19% less volatile than the S&P 500. Comparatively, Astrana Health has a beta of 1.2, meaning that its stock price is 20% more volatile than the S&P 500.
Bilibili received 391 more outperform votes than Astrana Health when rated by MarketBeat users. However, 80.00% of users gave Astrana Health an outperform vote while only 61.72% of users gave Bilibili an outperform vote.
Summary
Astrana Health beats Bilibili on 10 of the 19 factors compared between the two stocks.
Get Astrana Health News Delivered to You Automatically
Sign up to receive the latest news and ratings for ASTH and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Astrana Health Competitors List
Related Companies and Tools
This page (NASDAQ:ASTH) was last updated on 1/20/2025 by MarketBeat.com Staff
